The research team, led by Wenjing Guo and Chulin Chen from Nanjing University of Chinese Medicine and Jinling Hospital, searched eight databases from their inception through June 2026, spanning English and Chinese literature. After screening 3,525 records, they identified 18 longitudinal studies published between 2000 and 2025 that tracked quality of life in adults before and after starting home nutrition support. Fifteen of these studies, conducted across Asia, Europe, and North America, contained enough statistical information to be combined quantitatively. The cohort represented a clinically diverse population: eleven studies examined home enteral nutrition delivered by nasogastric tubes, gastrostomy or jejunostomy devices, or oral supplements, while seven examined home parenteral nutrition infused through central venous catheters, often overnight. Most patients had cancer, though Crohn’s disease, short bowel syndrome, intestinal dysmotility, and neurological disorders also appeared among the underlying diagnoses.

Measuring quality of life across such heterogeneous groups posed a methodological challenge, since the studies used different validated instruments, including the EORTC QLQ-C30 for cancer patients, the SF-36 general health survey, the EuroQol EQ-5D, the Inflammatory Bowel Disease Questionnaire, and the nutrition-specific NutriQoL scale. To combine these results, the researchers calculated standardized mean differences, a statistical measure expressing change in units of variability rather than raw score points, so that a positive value consistently indicates improvement. Because most studies did not report the correlation between baseline and follow-up measurements, a coefficient of r = 0.50 was assumed for the primary analysis, with extreme values of 0.10 and 0.90 tested in sensitivity analyses to confirm the results were robust to that assumption. Follow-up assessments were assigned to five predefined windows at 1, 2, 3, 4, and 6 months, and all pooled estimates came from random-effects models to account for the substantial statistical heterogeneity between studies.

The headline result is a clear temporal pattern. Quality of life improved significantly from baseline at 1 month, with a standardized mean difference of 0.29, and the improvement grew steadily stronger at 2 months (0.54), 3 months (0.64), and 4 months (0.61). All four of those estimates reached statistical significance, and the largest gains clustered in the 2-to-4-month range. In practical terms, patients recovering from nutritional deterioration, mastering their feeding equipment, and re-establishing daily routines experienced their most meaningful improvement during the first trimester of therapy. By 6 months, however, the pooled estimate had collapsed to just 0.09, with a 95 percent confidence interval spanning from negative 0.20 to 0.38, meaning the improvement could no longer be distinguished from no change at all.

The authors are careful about how this decline should be read. The studies contributing to each time point were not the same, no formal between-time-point comparison was possible, and the 6-month estimate rested on fewer trials. The pattern, they stress, is descriptive rather than proof of a continuous trajectory of improvement, peaking, and decline. Nevertheless, the sensitivity analyses using different correlation assumptions preserved the same overall shape, with larger estimates at 2 to 4 months than at 1 month and a numerically smaller, non-significant estimate at 6 months, which lends credibility to the temporal trend. Three additional studies that reported domain-specific scores but could not be pooled described consistent improvements in physical and psychosocial dimensions, including physical functioning, bodily pain, vitality, social functioning, and mental health, particularly in the early months of therapy.

Why would early gains fade? The researchers propose several interconnected mechanisms, all framed as hypotheses rather than validated explanations. The first is biological: most patients begin nutrition support in a state of depletion, burdened by weight loss and fatigue, and nutritional repletion restores energy balance and physical function, creating a physiological foundation for psychological adjustment. Qualitative work supports this staged recovery, with patients describing a transition to a new normal, growing self-efficacy in managing pumps and tubes, and a view of nutrition therapy as a lifeline that allows them to resume daily activities. This adaptation phase fits the Chronic Illness Trajectory Model, in which early mastery gives way to the slower realities of long-term dependence.

The second mechanism is the accumulating burden of the technology itself. For home enteral nutrition patients, especially those with head and neck cancer, physical tolerance of the tube may be acceptable while psychological tolerance is poor: two thirds of patients in one cited study longed for tube removal and nearly a quarter avoided going out in public. Home parenteral nutrition carries a different but equally consequential burden profile, including fear of catheter complications, sleep disruption from pump noise and nocturnal infusions, feelings of dependency reported by more than 70 percent of patients, and travel restrictions affecting more than half. These burdens are not static; they intensify as the novelty of home therapy wears off and device dependence becomes a permanent feature of life, progressively straining psychological reserves and social networks.

Third, disease trajectory likely shapes the curve. For patients with advanced cancer, disease progression can gradually overshadow the benefits of nutritional support, and prior longitudinal work found quality of life plateauing or declining after four months of home parenteral nutrition in that population, with the greatest benefit appearing around three months before survival dropped markedly. Patients with benign conditions such as Crohn’s disease follow a fundamentally different course, with more than 80 percent surviving five years on home parenteral nutrition, meaning their quality-of-life trajectory reflects chronic adaptation rather than progressive illness. Because the pooled estimates aggregate across these populations, the attenuation at 6 months may partly reflect the attrition of advanced cancer patients who became too ill to provide follow-up data rather than a universal phenomenon. High attrition rates in the single-arm studies, ranging from zero to 71 percent, underscore this concern.

The methodological quality of the included studies was acceptable overall, assessed with the Joanna Briggs Institute critical appraisal tools, but weaknesses remain. Blinding was rarely feasible in the randomized trials, most single-arm studies did not report how missing data were handled, and only four studies statistically adjusted for confounding. Subgroup analyses showed that the type of nutrition support, enteral versus parenteral, was not a significant source of heterogeneity, while the choice of quality-of-life instrument drove differences at the 1- and 3-month marks, though this finding is confounded by the fact that different instruments tend to track different diseases. No data existed beyond 6 months, and the restriction to English and Chinese publications, along with the fact that roughly 40 percent of the studies came from China, may limit generalizability to health systems with different home care models.

Even with those caveats, the clinical message is actionable. The first four months represent a window in which patients are demonstrably improving and in which nutritional optimization, structured education, and self-management support appear to coincide with the largest gains; the team’s own randomized trial of staged video education for home enteral nutrition patients showed reduced functional impairment, anxiety, and depression, and a telephone follow-up program has been shown to maintain health-related quality of life over time. The fading estimate at 6 months suggests that early improvement is not self-sustaining, and that care models focused narrowly on nutritional parameters and complication management may be missing what patients need next: vocational rehabilitation, psychosocial counseling, and restored social participation. The authors explicitly avoid claiming that interventions timed to this window are proven superior, but they propose a phase-adjusted, multidisciplinary approach as a working hypothesis for future testing. Longer prospective studies with formal comparisons between time points, patient-reported outcomes alongside qualitative experience, and disease-specific subgroup analyses will be needed to determine whether the six-month fade is an inevitable consequence of treatment, a reflection of underlying disease, or simply the cost of care systems that stop supporting patients precisely when the early momentum runs out.

Subject of Research: Longitudinal changes in quality of life among adults receiving home enteral or parenteral nutrition support

Article Title: Longitudinal changes in quality of life among patients receiving home nutrition support: a systematic review and meta-analysis

Article References: Guo, W., Chen, C., Yang, Y., Ni, J., & Wang, X. (2026). Longitudinal changes in quality of life among patients receiving home nutrition support: a systematic review and meta-analysis. Frontiers in Nutrition, 13, Article 1940328. https://doi.org/10.3389/fnut.2026.1940328

Image Credits: AI Generated

DOI: 10.3389/fnut.2026.1940328

Keywords: home nutrition support, home enteral nutrition, home parenteral nutrition, quality of life, meta-analysis, systematic review, intestinal failure, clinical nutrition, cancer patients, patient-reported outcomes, chronic disease, Longitudinal